Luvu Brands, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Luvu Brands, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $24.69M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $24.57M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $29.22M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $26.34M | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $23.11M | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $18.38M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $17.00M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $16.43M | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $16.93M | Oct 15, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $16.93M | Oct 4, 2017 |
| FY2017 | Jun 30, 2016 | $16.83M | Oct 4, 2017 |
| FY2016 | Jun 30, 2015 | $15.55M | Sep 27, 2016 |
| FY2015 | Jun 30, 2014 | $14.72M | Oct 13, 2015 |
| FY2014 | Jun 30, 2013 | $13.85M | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | $14.47M | Sep 30, 2013 |
| FY2012 | Jun 30, 2011 | $12.78M | Oct 11, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.47M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $6.53M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $7.19M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $6.00M | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $6.30M | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $5.53M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $4.42M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $4.80M | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $4.94M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $4.23M | Oct 4, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($448.0K) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | ($399.0K) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $1.20M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $604.0K | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $2.56M | Oct 14, 2022 |
| FY2013 | Jun 30, 2013 | ($288.5K) | Sep 30, 2013 |
| FY2013 | Jun 30, 2012 | ($782.4K) | Sep 30, 2013 |
| FY2012 | Jun 30, 2011 | ($801.3K) | Oct 11, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($69.0K) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $174.0K | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $1.54M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $946.0K | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $1.84M | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $1.45M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $410.0K | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $676.0K | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $736.0K | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $147.0K | Oct 4, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $167.3K | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $156.6K | Oct 14, 2025 |
| FY2016 | Jun 30, 2016 | $169.5K | Sep 27, 2016 |
| FY2016 | Jun 30, 2015 | $124.7K | Sep 27, 2016 |
| FY2015 | Jun 30, 2014 | $404.3K | Oct 13, 2015 |
| FY2014 | Jun 30, 2013 | $104.8K | Sep 29, 2014 |
| FY2013 | Jun 30, 2012 | $104.9K | Sep 30, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($410.0K) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $475.0K | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $661.0K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $387.0K | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $540.0K | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $367.0K | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $158.0K | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $210.0K | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $347.0K | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $26.0K | Oct 4, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $41.0K | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $71.0K | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $115.0K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $52.0K | Oct 16, 2023 |
| FY2021 | Jun 30, 2021 | $189.0K | Sep 28, 2021 |
| FY2021 | Jun 30, 2020 | $134.0K | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $113.0K | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $94.0K | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $70.0K | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $46.0K | Oct 4, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.76M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $9.13M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $10.61M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $10.38M | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $10.25M | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $5.45M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $4.09M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $3.71M | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $3.88M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $3.75M | Oct 4, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.34M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $6.30M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | $7.40M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $8.43M | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | $8.92M | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $6.72M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $6.24M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | $5.73M | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | $6.07M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $6.28M | Oct 4, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.42M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | $2.83M | Oct 14, 2025 |
| FY2025 | Jun 30, 2023 | $3.21M | Oct 14, 2025 |
| FY2024 | Jun 30, 2022 | $1.96M | Sep 30, 2024 |
| FY2023 | Jun 30, 2021 | $1.32M | Oct 16, 2023 |
| FY2022 | Jun 30, 2020 | ($1.27M) | Oct 14, 2022 |
| FY2021 | Jun 30, 2019 | ($2.16M) | Sep 28, 2021 |
| FY2020 | Jun 30, 2018 | ($2.16M) | Oct 1, 2020 |
| FY2019 | Jun 30, 2017 | ($2.19M) | Oct 11, 2019 |
| FY2018 | Jun 30, 2016 | ($2.53M) | Oct 15, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($4.64M) | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | ($4.19M) | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | ($3.79M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($4.99M) | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | ($5.59M) | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | ($8.16M) | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | ($9.02M) | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | ($8.86M) | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | ($9.01M) | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | ($9.21M) | Oct 4, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.0K | Oct 14, 2025 |
| FY2022 | Jun 30, 2022 | $859.0K | Oct 14, 2022 |
| FY2022 | Jun 30, 2021 | $977.0K | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | $1.15M | Sep 28, 2021 |
| FY2021 | Jun 30, 2019 | $649.0K | Sep 28, 2021 |
| FY2020 | Jun 30, 2018 | $431.0K | Oct 1, 2020 |
| FY2019 | Jun 30, 2017 | $742.0K | Oct 11, 2019 |
| FY2018 | Jun 30, 2016 | $545.0K | Oct 15, 2018 |
| FY2017 | Jun 30, 2015 | $492.0K | Oct 4, 2017 |
| FY2016 | Jun 30, 2014 | $592.0K | Sep 27, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | $154.4K | Oct 13, 2015 |
| FY2014 | Jun 30, 2014 | $70.7K | Sep 29, 2014 |
| FY2013 | Jun 30, 2013 | $40.9K | Sep 30, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Oct 1, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Oct 1, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 76.83M | Oct 14, 2025 |
| FY2025 | Jun 30, 2024 | 76.55M | Oct 14, 2025 |
| FY2024 | Jun 30, 2023 | 76.55M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 76.05M | Oct 16, 2023 |
| FY2022 | Jun 30, 2021 | 75.04M | Oct 14, 2022 |
| FY2021 | Jun 30, 2020 | 73.45M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 73.45M | Oct 1, 2020 |
| FY2019 | Jun 30, 2018 | 73.45M | Oct 11, 2019 |
| FY2018 | Jun 30, 2017 | 73.45M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | 71.45M | Oct 4, 2017 |